The Latest Breaking News from JNJ

As the demand for healthcare products and solutions continues to rise, the medical industry is poised for remarkable growth. Therefore, quality medical stocks Johnson & Johnson (JNJ), AstraZeneca (AZN), and Astellas Pharma (ALPMY) could be the ideal investments for your portfolio amid current market uncertainties. Read on….

The United States has yet to enter a recession, but even if we continue in this downturn or come out of it, these three Dividend Kings are top performers to consider.

Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on.

Johnson & Johnson rips off Band-Aid and spits out Listerine in a bid to boost margins.

Here Are 2 Ideas Depending on How the Next Fed Announcement Goes.

Despite an uncertain macro environment, healthcare giant Johnson & Johnson (JNJ) reported outstanding results in 2022, reflecting its business segments' continued strength. Moreover, the company has a history of increasing dividends for 60 consecutive years. Given its sustained business momentum and steady dividend payments, investors seem to stay committed to…

Trading Smarter, Not Harder With the 50-Day Moving Average Strategy

As investors continue to digest the news of the recent bank collapses and the Federal Reserve’s quarter-percentage-point rate hike, the stock market outlook seems bumpy for some time. With speculations of an economic slowdown, investing in prominent large-cap stocks Johnson & Johnson (JNJ), Visa (V), and Merck & Co. (MRK)…

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

Tighter bank lending and the Fed’s continued fight against inflation will likely push the economy into a recession this year. In this scenario, investors can look to invest in the pharma giant Johnson & Johnson (JNJ), given its financial strength, reliable dividend payments, and solid growth prospects. Read more….